Standard BioTools
LAB
LAB
109 hedge funds and large institutions have $179M invested in Standard BioTools in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 43 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 24
76% less call options, than puts
Call options by funds: $214K | Put options by funds: $877K
Holders
109
Holding in Top 10
–
Calls
$214K
Puts
$877K
Top Buyers
| 1 | +$9.59M | |
| 2 | +$3.05M | |
| 3 | +$1.44M | |
| 4 |
NIM
Needham Investment Management
New York
|
+$945K |
| 5 |
Rockefeller Capital Management
New York
|
+$405K |
Top Sellers
| 1 | -$15M | |
| 2 | -$4.9M | |
| 3 | -$3.02M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.74M |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$1.64M |